Jpmorgan Chase & CO Natera, Inc. Put Options Transaction History
Jpmorgan Chase & CO
- $1.22 Trillion
- Q3 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding NTRA
# of Institutions
527Shares Held
118MCall Options Held
308KPut Options Held
191K-
Vanguard Group Inc Valley Forge, PA11.4MShares$1.83 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY6.77MShares$1.09 Billion0.02% of portfolio
-
Farallon Capital Management LLC San Francisco, CA4.56MShares$730 Million2.91% of portfolio
-
Fred Alger Management, LLC New York, NY4.01MShares$643 Million2.57% of portfolio
-
Stanley Druckenmiller Duquesne Family Office LLC | New York, Ny3.57MShares$572 Million15.34% of portfolio
About Natera, Inc.
- Ticker NTRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 96,957,400
- Market Cap $15.5B
- Description
- Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...